No registrations found.
ID
NL-OMON20901
Source
NTR
Health condition
Erfelijke hemochromatose
Sponsors and support
Primary sponsor
:
-
Source(s) of monetary or material Support
:
-
Intervention
Outcome measures
Primary outcome
correlatie tussen index en aantal aderlatingen
Secondary outcome
-
Study objective
Een predictor vinden in de vorm van ferritine bij diagnose/leeftijd bij diagnose die het aantal aderlatingen per jaar in onderhoudsbehandeling van hemochromatose patienten kan voorspellen
Study design
-
Intervention
not applicable
Public
Scientific
Inclusion criteria
Homozygoot C282Y hemochromatose
in onderhoudsbehandeling voor tenminste 1 jaar.
Exclusion criteria
Patiënten met andere genmutaties die tot hemochromatose leiden. Nog niet in onderhoudsbehandeling
Design
Study type
:
Observational non invasive
Intervention model
:
Other
Allocation
:
Non controlled trial
Masking
:
Open (masking not used)
Control
:
N/A , unknown
Recruitment
NL
Recruitment status
:
Recruiting
Start date (anticipated)
:
Enrollment
:
85
Type
:
Anticipated
Positive opinion
Date
:
Application type
:
First submission
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL4540 |
| NTR-old | NTR4684 |
| Other | METC : 14-N-89 |